Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1429, 2012-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PPIs plus clopidogrel not linked to increase in CV events
Reactions Weekly, Vol. 1, Iss. 1322, 2010-01 ,pp. :
Access to resources
Recommend
Risk of CV disorders with insulin or sulfonylureas
Reactions Weekly, Vol. 1, Iss. 1222, 2008-01 ,pp. :
Hopes for fewer deaths, lower costs with genetics guiding dosing
Reactions Weekly, Vol. 1, Iss. 1342, 2011-01 ,pp. :
Rosiglitazone CV risk relative to metformin, sulfonylurea
Reactions Weekly, Vol. 1, Iss. 1161, 2007-01 ,pp. :
Serious adverse CV events with varenicline
Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. :